Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …

Congenital human cytomegalovirus (HCMV) infection can result in severe and permanent
neurological injury in newborns, and vaccine development is accordingly a major public …

This study compared the incidence of CMV infection/disease in de novo kidney transplant
recipients receiving everolimus or mycophenolate and no CMV pharmacological …

Infectious complications have been considered as a major cause of morbidity and mortality
after kidney transplantation, especially in the Asian population. Therefore, prevention, early …

The recent approval of letermovir marks a new era of therapy for human cytomegalovirus
(HCMV) infections, particularly for the prevention of HCMV disease in hematopoietic stem …

Little is known on the landscape of viruses that reside within our cells, nor on the interplay
with the host imperative for their persistence. Yet, a lifetime of interactions conceivably have …

Cytomegalovirus (CMV) is a common viral pathogen in the transplant population and is
associated with significant morbidity and mortality. CMV prevention is paramount; however …

The impact of cytomegalovirus (CMV) serostatus on kidney transplant outcomes in an era
when CMV prophylactic and preemptive strategies are used routinely is not clearly …

Cytomegalovirus (CMV) infection remains a major complication of solid organ
transplantation. Because of management of CMV is variable among transplant centers, in …

Rationale: Cytomegalovirus (CMV), which is one of the most common infections after lung
transplantation, is associated with chronic lung allograft dysfunction and worse post …